Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Bamboos Health Care Holdings Ltd ( (HK:2293) ) just unveiled an update.
Bamboos Health Care Holdings Limited has updated the composition of its board of directors effective 22 May 2026, confirming Ms. Hai Hiu Chu as executive director, chairman and chief executive officer, supported by three independent non-executive directors. The company has also clarified the membership and leadership of its audit, remuneration and nomination committees, signaling an emphasis on structured corporate governance and oversight for investors and other stakeholders.
Independent directors Dr. Chan Kai Yue Jason, Mr. Wong Kon Man Jason and Mr. Tang Yi Hoi will each serve specific roles across the three committees, with Mr. Wong chairing the audit committee and Mr. Tang chairing the remuneration committee, while Ms. Hai chairs the nomination committee. This allocation of responsibilities is designed to strengthen checks and balances within the board, enhance transparency in areas such as financial reporting and executive pay, and support robust nomination processes for future board appointments.
More about Bamboos Health Care Holdings Ltd
Bamboos Health Care Holdings Limited, incorporated in the Cayman Islands and listed in Hong Kong under stock code 2293, operates in the healthcare services sector. The company is overseen by a board comprising an executive director who also serves as chairman and CEO, alongside several independent non-executive directors who support governance through key board committees.
Average Trading Volume: 73,764
Technical Sentiment Signal: Sell
Current Market Cap: HK$152.9M
Find detailed analytics on 2293 stock on TipRanks’ Stock Analysis page.